DBV Technologies SA DBVT:NASDAQ

RT Quote | NASDAQ | USD
Last | 4:00 PM EDT
5.09quote price arrow down-0.04 (-0.78%)
Volume
46,931
52 week range
1.35 - 7.38
Loading...
  • Open5.12
  • Day High5.13
  • Day Low5.06
  • Prev Close5.13
  • 52 Week High7.38
  • 52 Week High Date01/19/21
  • 52 Week Low1.35
  • 52 Week Low Date10/29/20

Key Stats

  • Market Cap575.13M
  • Shares Out109.76M
  • 10 Day Average Volume0.06M
  • Dividend-
  • Dividend Yield-
  • Beta2.85
  • YTD % Change95.04

KEY STATS

  • Open5.12
  • Day High5.13
  • Day Low5.06
  • Prev Close5.13
  • 52 Week High7.38
  • 52 Week High Date01/19/21
  • 52 Week Low1.35
  • 52 Week Low Date10/29/20
  • Market Cap575.13M
  • Shares Out109.76M
  • 10 Day Average Volume0.06M
  • Dividend-
  • Dividend Yield-
  • Beta2.85
  • YTD % Change95.04

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date10/26/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On DBV Technologies SA

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
DBV Technologies SA is a France-based clinical-stage biopharmaceutical company focused on changing the field of immunotherapy by developing a technology platform called Vaskin. The Company's therapeutic approach is based on epicutaneous immunotherapy, or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin. It dedicates its technology to treat patients, including infants and children, suffering from...
Michel de Rosen
Non-Executive Chairman
Daniel Tasse
Chief Executive Officer
Sebastien Robitaille
Chief Financial Officer
Address
177-181 avenue Pierre Brossolette
Montrouge
92120
France